Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk Patients

Publisher： Karger

E-ISSN： 2235-0802|4|2|82-92

ISSN： 2235-0640

Source： European Thyroid Journal, Vol.4, Iss.2, 2015-06, pp. : 82-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Prospective Study Showing an Excellent Response of Patients with Low-Risk Differentiated Thyroid Cancer Who Did Not Undergo Radioiodine Remnant Ablation after Total Thyroidectomy

By  

European Thyroid Journal, Vol. 5, Iss. 1, 2015-11 ,pp. : 44-49

Karger

Access to resources Recommend Favorite

Prospective Study Confirms that Radioiodine Remnant Ablation Is Not Necessary in Low-Risk Differentiated Thyroid Cancer

By  

European Thyroid Journal, Vol. 5, Iss. 1, 2016-01 ,pp. : 7-8

Karger

Access to resources Recommend Favorite

Patients with Multifocal Macroscopic Papillary Thyroid Carcinoma Have a Low Risk of Recurrence at Early Follow-Up after Total Thyroidectomy and Radioactive Iodine Treatment

By  

European Thyroid Journal, Vol. 6, Iss. 1, 2016-10 ,pp. : 31-39

Karger

Access to resources Recommend Favorite

Feasibility of an Early Discontinuation of Thyroid Hormone Treatment in Very-Low-Birth-Weight Infants at Risk for Transient or Permanent Congenital Hypothyroidism

By  

Hormone Research in Paediatrics, Vol. 85, Iss. 2, 2016-0 ,pp. : 131-139

Karger

Access to resources Recommend Favorite

Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer?

By  

European Thyroid Journal, Vol. 5, Iss. 4, 2016-10 ,pp. : 261-267

Karger

Access to resources Recommend Favorite